Cancer Treatment Centers of America (CTCA) has teamed with 3 other companies to offer better healthcare to their patients.
CTCA serves adult cancer patients from around the world at its five locations in Atlanta, Chicago, Philadelphia, Phoenix, and Tulsa. These patients get advancements in cancer treatment. CTCA also offers surgery, radiation, immunotherapy, and chemotherapy. As an added bonus, patients get therapies designed to help them physically and emotionally while they deal with the side effects of their treatments.
Cancer Treatment Centers of America believes that each person’s cancer is as different and unique as they are, that’s the reason each patient’s treatment is unique in it’s own way.
Allscripts helps caregivers deliver better care to patients through their healthcare information technology solutions.
Nanthealth offers unique software, middleware, and hardware systems that doctors and hospitals use to track patient records, which improves patient outcomes.
Eviti offers a support platform for physicians to see treatment and outcomes in order to select a clinically appropriate treatment.
These four are teaming up to bring The Clinical Pathways Program to light in order to help with the cancer treatment programs. This will give patients a chance to review treatments that are safe and efficient.
Planning for this project began in early 2016 to help the patients, as well as, physicians benefit from an integrated solution.
Not only are patients and physicians able to benefit from this program, but insurance providers can expedite approval by providing the necessary clinical data they need to support treatment strategies.
According to the article, “Cancer Treatment Centers of America® Partners with Allscripts and NantHealth to Launch Clinical Pathways, a Comprehensive and Custom Oncology Treatment Platform,” he Clinical Pathways Program improves the quality of care CTCA offers their patients by improving the chemotherapy regimen selection and ordering process. Physicians are able to get information on over 2700 regimens that cover all cancers and cancer subtypes. This gives the patient more knowledge than ever before on how the regimen is offered, the outcome, costs, and toxicities.
Clinical Pathways is available at all five CTCA locations for use with every patient.